Imaging the Pathophysiology of AMN in Mice and Humans

小鼠和人类 AMN 病理生理学成像

基本信息

  • 批准号:
    7869234
  • 负责人:
  • 金额:
    $ 17.56万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-06-01 至 2011-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The proposed interdisciplinary study allows the candidate to further develop his knowledge of MR physics and expertise in imaging studies of adrenomyeloneuropathy (AMN), a form of adrenoleukodystrophy (ALD), while providing rigorous exposure to the clinical and biological side of this research. The goal is to increase the candidate's expertise in multiple areas necessary to his proposed research project and future career development. These areas include genetics of peroxisomal disorders, lipid metabolism, and spatial aspects of nuclear magnetic resonance spectroscopy. The proposal builds nicely on the candidate's prior experience with Dr. Moser at Johns Hopkins and extends his studies to the animal model. The candidate is in a world-renown environment for both MR imaging and neuroscience. This Award will provide the guidance and tools necessary for him to become a successful, independent researcher. The 5 year research training program consists of 1) coursework and mentoring relationships on the science of high-field magnetic resonance that the candidate is currently lacking, 2) a 2 year rigorous training in animal imaging, and 3) collaborative translational studies with experts in the field of lipid metabolism and peroxisomal disorders. The research portion of this application will allow him to examine the histopathological and biochemical correlate of advanced MR techniques in the mouse model of ALD. This has never been done before and likely to reveal insight into the fundamental dynamics of demyelination. Further, the proposal encompasses application of novel therapeutics to normalize lipid metabolism and stabilize myelin membrane integrity. Hypotheses include: 1) in the animal model of ALD, measures of diffusion tensor imaging can assess the density of white matter tracts in the mouse and measures of single voxel proton MR spectroscopy reflect changes in lipid composition of the brain, and 2) in ALD patients, metabolic changes seen on proton MR spectroscopic imaging herald lesion development on conventional MRI. Our results will yield a noninvasive means of gauging the effects of experimental and therapeutic manipulations of lipid chemistry upon specific neuroanatomic structures. Ultimately, insights gained in these studies of ALD/AMN may prove beneficial to other neurodegenerative diseases, such as amyotrophic lateral sclerosis or Parkinson's and Alzheimer's diseases.
描述(由申请人提供):拟议的跨学科研究允许候选人进一步发展他对肾上腺瘤肌病(AMN)成像研究中MR物理学和专业知识的了解,这是一种肾上腺素肌营养不良(ALD)的一种形式,同时为这项研究的临床和生物学方面提供了严格的暴露。目的是提高候选人在其拟议的研究项目和未来职业发展所需的多个领域的专业知识。这些领域包括过氧化物酶体疾病,脂质代谢以及核磁共振光谱的空间方面的遗传学。该提案很好地基于候选人在约翰·霍普金斯(Johns Hopkins)的摩泽尔博士(Moser)的先前经验,并将其研究扩展到动物模型。该候选人处于MR成像和神经科学的世界享有盛誉的环境中。该奖项将为他成为一名成功的独立研究人员提供必要的指导和工具。为期5年的研究培训计划包括1)候选人目前缺乏的高场磁共振科学的课程和指导关系,2)2)在动物成像方面进行了2年的严格培训,以及3)与脂质代谢和过氧化物症领域专家的协作转化研究。本应用的研究部分将使他能够检查ALD小鼠模型中高级MR技术的组织病理学和生化相关性。这从未有过,并且很可能揭示了对脱髓鞘基本动态的见解。此外,该提案涵盖了新型疗法的应用,以使脂质代谢正常化并稳定髓鞘膜完整性。 Hypotheses include: 1) in the animal model of ALD, measures of diffusion tensor imaging can assess the density of white matter tracts in the mouse and measures of single voxel proton MR spectroscopy reflect changes in lipid composition of the brain, and 2) in ALD patients, metabolic changes seen on proton MR spectroscopic imaging herald lesion development on conventional MRI.我们的结果将产生一种无创的手段,以衡量脂质化学对特定神经解剖结构的实验和治疗操作的影响。最终,在这些ALD/AMN的研究中获得的见解可能对其他神经退行性疾病有益,例如肌萎缩性侧索硬化症或帕金森氏症和阿尔茨海默氏病。

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Levodopa response reveals sepiapterin reductase deficiency in a female heterozygote with adrenoleukodystrophy.
左旋多巴反应揭示了患有肾上腺脑白质营养不良的女性杂合子中墨蝶呤还原酶缺乏。
  • DOI:
    10.1007/8904_2011_65
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Thibert,Ronald;Hyland,Keith;Chiles,Joe;Steinberg,Steven;Eichler,Florian
  • 通讯作者:
    Eichler,Florian
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FLORIAN S EICHLER其他文献

FLORIAN S EICHLER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FLORIAN S EICHLER', 18)}}的其他基金

The Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN)
全球脑白质营养不良倡议临床试验网络 (GLIA-CTN)
  • 批准号:
    10704432
  • 财政年份:
    2019
  • 资助金额:
    $ 17.56万
  • 项目类别:
Myelin Disorders Biorepository Project (MDBP) at the Biospecimen Exchange for Neurological Disorders (BioSEND)
神经疾病生物样本交换中心 (BioSEND) 的髓磷脂疾病生物储存库项目 (MDBP)
  • 批准号:
    10850332
  • 财政年份:
    2019
  • 资助金额:
    $ 17.56万
  • 项目类别:
Utility of advanced MRI and wearable technology to identify sensory motor outcome measures in leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL)
利用先进的 MRI 和可穿戴技术来确定脑干和脊髓受累以及乳酸升高 (LBSL) 的白质脑病的感觉运动结果测量
  • 批准号:
    10406744
  • 财政年份:
    2019
  • 资助金额:
    $ 17.56万
  • 项目类别:
The Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN)
全球脑白质营养不良倡议临床试验网络 (GLIA-CTN)
  • 批准号:
    9804283
  • 财政年份:
    2019
  • 资助金额:
    $ 17.56万
  • 项目类别:
The Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN)
全球脑白质营养不良倡议临床试验网络 (GLIA-CTN)
  • 批准号:
    10266084
  • 财政年份:
    2019
  • 资助金额:
    $ 17.56万
  • 项目类别:
ALD Healthy Planet Project
ALD 健康星球计划
  • 批准号:
    10851183
  • 财政年份:
    2019
  • 资助金额:
    $ 17.56万
  • 项目类别:
The Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN)
全球脑白质营养不良倡议临床试验网络 (GLIA-CTN)
  • 批准号:
    10675461
  • 财政年份:
    2019
  • 资助金额:
    $ 17.56万
  • 项目类别:
Validation of the GMFC-MLD
GMFC-MLD 的验证
  • 批准号:
    10842097
  • 财政年份:
    2019
  • 资助金额:
    $ 17.56万
  • 项目类别:
The Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN)
全球脑白质营养不良倡议临床试验网络 (GLIA-CTN)
  • 批准号:
    10442668
  • 财政年份:
    2019
  • 资助金额:
    $ 17.56万
  • 项目类别:
The Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN)
全球脑白质营养不良倡议临床试验网络 (GLIA-CTN)
  • 批准号:
    10023202
  • 财政年份:
    2019
  • 资助金额:
    $ 17.56万
  • 项目类别:

相似海外基金

Neurocognitive and neuroimaging markers of emerging cerebral adrenoleukodystrophy
新发脑性肾上腺脑白质营养不良的神经认知和神经影像学标志物
  • 批准号:
    10524184
  • 财政年份:
    2022
  • 资助金额:
    $ 17.56万
  • 项目类别:
Neurocognitive and neuroimaging markers of emerging cerebral adrenoleukodystrophy
新发脑性肾上腺脑白质营养不良的神经认知和神经影像学标志物
  • 批准号:
    10678672
  • 财政年份:
    2022
  • 资助金额:
    $ 17.56万
  • 项目类别:
Improved Outcome Assessments in Adrenomyeloneuropathy
改进肾上腺脊髓神经病的结果评估
  • 批准号:
    10675469
  • 财政年份:
    2019
  • 资助金额:
    $ 17.56万
  • 项目类别:
Improved Outcome Assessments in Adrenomyeloneuropathy
改进肾上腺脊髓神经病的结果评估
  • 批准号:
    10923621
  • 财政年份:
    2019
  • 资助金额:
    $ 17.56万
  • 项目类别:
Improved Outcome Assessments in Adrenomyeloneuropathy
改进肾上腺脊髓神经病的结果评估
  • 批准号:
    10266087
  • 财政年份:
    2019
  • 资助金额:
    $ 17.56万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了